Aveanna Healthcare Holdings

Aveanna Healthcare Holdings, Inc. operates as a holding company. The firm, through its subsidiaries, provides pediatric home care services. It offers pediatric therapy, adult skilled nursing, and medical services. The company was founded on November 30, 2016 and is headquartered in Atlanta, GA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Aveanna Healthcare reports Q4 growth, eyes rate increases for 2023

Aveanna Healthcare's Q4 performance showed revenue growth but a decrease in adjusted EBITDA due to labor costs.
The company aims to drive growth in 2023 through rate increases, expanding preferred payers, and optimizing staffing rates.
Challenges include caregiver supply, cash flow turnaround, and potential hurdles in passing rate increases in key states.

Aveanna Healthcare reports revenue growth, legal wins, and cash flow focus

Aveanna Healthcare Holdings navigated Q1 with revenue growth, cost challenges, and legal wins, aiming for positive cash flows in the second half.
The company's focus on caregiver recruitment, preferred payer relationships, and strategic investments positions them for growth despite industry concerns.
While facing regulatory uncertainties and cash flow challenges, Aveanna's strong liquidity and operational strategies provide a foundation for future success.

Aveanna Healthcare reports revenue growth and strategic payer mix focus

Aveanna Healthcare Holdings demonstrated solid financial performance in Q2 2023, with revenue growth and increased EBITDA, despite challenges in the labor market.
The company's strategic focus on preferred payer mix, rate negotiations, and advocacy efforts positions it well for future growth and financial stability.
While facing operational challenges and ongoing negotiations, Aveanna's proactive approach to revenue optimization and advocacy bodes well for long-term success.
Maintaining liquidity, raising revenue guidance, and emphasizing alignment with value-based payers underscore Aveanna's commitment to financial resilience and growth.

Aveanna Healthcare reports strong Q3 performance amidst industry challenges

Aveanna Healthcare Holdings delivered a robust performance in Q3, showcasing revenue growth, improved margins, and enhanced EBITDA, despite industry challenges.
The company's strategic focus on rate increases, preferred payers, and maintaining liquidity positions it well for sustained growth and financial stability.
While facing challenges like caregiver shortages and wage inflation, Aveanna's positive outlook and disciplined approach signal opportunities for future growth and profitability.

Aveanna Healthcare reports robust Q4 earnings and outlines growth strategies

Aveanna Healthcare Holdings demonstrated strong financial performance in Q4 2023 and full year 2023, with revenue and adjusted EBITDA showing significant growth.
The company's strategic initiatives, focus on preferred payers, and plans for margin expansion in 2024 position Aveanna for continued success and growth.
While facing challenges in the labor market and payer dynamics, Aveanna's emphasis on cost efficiencies and capital management presents opportunities for sustained profitability and market competitiveness.

Aveanna Healthcare reports strong Q1 growth, eyes sustained revenue

Aveanna Healthcare Holdings' Q1 2024 performance reflects revenue and EBITDA growth driven by strategic initiatives and operational strengths.
While facing challenges in securing rate increases and managing cost efficiencies, Aveanna is well-positioned to capitalize on opportunities for sustained growth.
With a focus on partnerships, caregiver capacity enhancements, and financial stability, Aveanna is poised for continued success and operational excellence.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Aveanna Healthcare Holdings, Inc. engages in providing home care services to patients. It operates through the following business segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing services. The HHH segment provides home health, hospice, and program services to predominately elderly populations. The MS segment offers supplies to patients requiring enteral nutrition services or respiratory care. The company was founded on November 30, 2016 and is headquartered in Atlanta, GA.

Fulcrum Therapeutics Inc

Revolution Medicines

As of July 16, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Top 3 Health Care Stocks That Should Keep You Up At Night This Quarter

Ikena Oncology

Velocity Financial

IKNA, AVAH, and VEL made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 12, 2024.

Best Momentum Stocks to Buy for July 12th

ATLANTA, May 20, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the UBS Healthcare Services Cape Cod Summit in Chatham, MA on Tuesday, June 4, 2024, and the Jefferies Global Healthcare Conference in New York on Wednesday, June 5, 2024.

Aveanna to Participate at the UBS Healthcare Services Cape Cod Summit and Jefferies Global Healthcare Conference

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH ) Q1 2024 Earnings Conference Call May 9, 2024 10:00 AM ET Company Participants Debbie Stewart - CAO Jeff Shaner - CEO Matt Buckhalter - CFO Conference Call Participants Ben Hendrix - RBC Capital Markets Scott Fidel - Stephens Pito Chickering - Deutsche Bank Brian Tanquilut - Jefferies Operator Good morning, and welcome to Aveanna Healthcare Holdings' First Quarter 2024 Earnings Conference Call. Today's call is being recorded, and we have allocated one hour for prepared remarks and Q&A.

Aveanna Healthcare Holdings Inc. (AVAH) Q1 2024 Earnings Call Transcript

Although the revenue and EPS for Aveanna (AVAH) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Compared to Estimates, Aveanna (AVAH) Q1 Earnings: A Look at Key Metrics

Aveanna Healthcare (AVAH) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.05 per share a year ago.

Aveanna Healthcare (AVAH) Reports Q1 Loss, Tops Revenue Estimates

ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three-month period March 30, 2024.

Aveanna Healthcare Holdings Announces First Quarter 2024 Financial Results and Revised 2024 Outlook

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Aveanna (AVAH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.

Countdown to Aveanna (AVAH) Q1 Earnings: Wall Street Forecasts for Key Metrics

ATLANTA, May 03, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the Barclays Leveraged Finance Conference in Austin, TX on May 21, 2024. Management will host 1x1 investor meetings that day.

Aveanna to Participate at the Barclays Leveraged Finance Conference

ATLANTA, May 01, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the RBC Capital Markets Global Healthcare Conference in New York on May 14, 2024.

Aveanna to Participate at the RBC Capital Markets Global Healthcare Conference

ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) --  Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its first quarter results before the market open on Thursday, May 9, 2024, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day.

Aveanna Announces First Quarter 2024 Earnings Release Date and Conference Call

ATLANTA, April 03, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Jerry Perchik to serve as Chief Legal Officer and Secretary, effective April 29, 2024. “I am pleased to announce the appointment of Jerry to the Chief Legal Officer and Secretary role.

Aveanna Healthcare Holdings Announces Appointment of Chief Legal Officer and Secretary

OKLAHOMA CITY--(BUSINESS WIRE)-- #FedermanSherwood--Federman & Sherwood Investigates Aveanna Healthcare for Data Breach.

Federman & Sherwood Investigates Aveanna Healthcare for Data Breach

Aveanna Healthcare Holdings Inc. (AVAH) Q4 2023 Earnings Call Transcript

While the top- and bottom-line numbers for Aveanna (AVAH) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Aveanna (AVAH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Aveanna Healthcare (AVAH) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.03 per share a year ago.

Aveanna Healthcare (AVAH) Reports Q4 Loss, Tops Revenue Estimates

ATLANTA, March 14, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three-month period and fiscal year ended December 30, 2023.

Aveanna Healthcare Holdings Announces Fourth Quarter 2023 Financial Results and 2024 Outlook

ATLANTA, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its fourth quarter and full year results before the market open on Thursday, March 14, 2024, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day.

Aveanna Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call

Antero Midstream Partners

Dillard's

Emergent BioSolutions

Con Ed

Harmony Gold Mining Co Ltd

Tellurian

While it's usually a solid principle to bet alongside Wall Street's top experts, sometimes, they don't get it right, which brings us to contrarian analyst picks. You know how I've been supporting my arguments with analyst ratings and price targets?

Contrarian Calls: 7 Analyst ‘Sell' Ratings That Should Be ‘Buys'

ATLANTA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced the appointment of Matt Buckhalter to serve as Chief Financial Officer and continuing in the role of Principal Financial Officer, effective January 1, 2024. Mr. Buckhalter was appointed to serve as Interim Chief Financial Officer and Principal Financial Officer in July, 2023.

Aveanna Healthcare Holdings Announces Appointment of Chief Financial Officer

Here is how Aveanna Healthcare (AVAH) and Bausch Health (BHC) have performed compared to their sector so far this year.

Has Aveanna Healthcare (AVAH) Outpaced Other Medical Stocks This Year?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH ) Q3 2023 Earnings Conference Call November 9, 2023 10:00 AM ET Company Participants Shannon Drake - Chief Legal Officer Jeffrey Shaner - Chief Executive Officer David Afshar - Chief Financial Officer Matt Buckhalter - Interim Chief Financial Officer Debbie Stewart - Chief Accounting Officer Conference Call Participants Operator Good morning and welcome to Aveanna Healthcare Holdings Third Quarter 2023 Earnings Conference Call. Today's call is being recorded, and we've allocated one hour for prepared remarks and Q&A.

Aveanna Healthcare Holdings Inc. (AVAH) Q3 2023 Earnings Call Transcript

Although the revenue and EPS for Aveanna (AVAH) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Aveanna (AVAH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

ATLANTA, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three and nine-month periods ended September 30, 2023.

Aveanna Healthcare Holdings Announces Third Quarter 2023 Financial Results

Get a deeper insight into the potential performance of Aveanna (AVAH) for the quarter ended September 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

News for Aveanna Healthcare Holdings Stock (AVAH)